Management of Tubo-ovarian Abscess: a Single Center Experience

Study Overview
=================
Brief Summary
-----------------
Electronic database of our tertiary obstetrics and gynecology clinic was searched for patients who were treated for tub-ovarian abscess during the last 10 years (January 2010- November 2020). Patients' biometric data, admission date and duration, medical and surgical treatment modalities were recorded using an Excel sheet. Patients will be evaluated on the basis of the treatment they receive, length of treatment, if surgically treatment the type of surgery performed. Hospitalization length, readmission, recurrence will be compared between treatment modalities.

Detailed Description
-----------------
This retrospective study is conducted at Health Sciences University Turkey, Sisli Hamidiye Etfal Training and Research Hospital Department of Obstetrics and Gynecology. Electronic database was searched for patients who were treated for tub-ovarian abscess during the last 10 years (January 2010- November 2020). Patients' biometric data, admission date and duration, medical and surgical treatment modalities were recorded using an Excel sheet. Patients will be evaluated on the basis of the treatment they receive, length of treatment, if surgically treatment the type of surgery performed. Hospitalization length, readmission, recurrence will be compared between treatment modalities. A change in management strategy over the years if any will be reported.

Official Title
-----------------
Management of Tuba-ovarian Abscess: a 10 Year Single-center Experience

Conditions
-----------------
Tubo-ovarian Abscess

Intervention / Treatment
-----------------
* Other: tuboovarian abscess


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: presence of a pelvic mass > 3 cm with transvaginal ultrasound or magnetic resonance imaging indication abscess cervical and uterine tenderness abdominal rebound-defense under physical examination indication peritoneal irritation presence of symptoms such as fever, pelvic pain and increase in laboratory infection parameters Exclusion Criteria: Patients with known malignities Patients with incomplete data in the clinic's electronic database Patients who continued their treatment at other centers

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
Female

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: tuboovarian abscess|Evaluating the surgical and medical management of tuboovarian abscess|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluating the management of tuboovarian abscess on the basis of surgical or medical modalities by assessing hospitalization duration and recurrence | Patients' demographics data (age, gravity, parity, presence of additional comorbidities and BMI) will be recorded. Their laboratory assessment of infection prior to treatment begin such as CRP an procalcitonin will be recorded. Their treatment modalities in terms of surgery or antibiothepry, duration of hospitalization and recurrence will be recorded. Statistical analysis will be done using SPSS. Student's t test will be used for comparison where necessary. Significance will be evaluated using p-value. | 10 years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
abscess drainage, abscess size, medical treatment, surgical treatment